HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dusan Hirjak Selected Research

Antipsychotic Agents (Antipsychotics)

11/2021Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon.
1/2021White matter microstructure alterations in cortico-striatal networks are associated with parkinsonism in schizophrenia spectrum disorders.
1/2020Neurological soft signs in schizophrenia spectrum disorders are not confounded by current antipsychotic dosage.
1/2020Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses - European consensus on assessment and perspectives.
12/2019Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients.
4/2016Multiparametric mapping of neurological soft signs in healthy adults.
1/2016Structural network changes in patients with major depression and schizophrenia treated with electroconvulsive therapy.
2/2015Neural network activity and neurological soft signs in healthy adults.
1/2015Motor abnormalities and basal ganglia in schizophrenia: evidence from structural magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dusan Hirjak Research Topics

Disease

24Schizophrenia (Dementia Praecox)
09/2022 - 01/2015
11Catatonia
09/2022 - 10/2019
5Parkinsonian Disorders (Parkinsonism)
09/2022 - 01/2020
4Mental Disorders (Mental Disorder)
03/2022 - 02/2013
4Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 01/2019
3Movement Disorders (Movement Disorder)
12/2021 - 01/2020
2Psychomotor Agitation (Akathisia)
09/2022 - 01/2020
2Pathologic Processes
04/2016 - 02/2015
1Tardive Dyskinesia
09/2022
1Neuroleptic Malignant Syndrome
11/2021
1Dyskinesias (Dyskinesia)
01/2020
1Autism Spectrum Disorder
06/2018
1Paraplegia (Spastic Paraplegia)
02/2013
1Wounds and Injuries (Trauma)
10/2012
1Intraoperative Complications
10/2012
1Osteoarthritis
03/2011

Drug/Important Bio-Agent (IBA)

14Silver Sulfadiazine (SSD)FDA LinkGeneric
09/2022 - 01/2019
9Antipsychotic Agents (Antipsychotics)IBA
11/2021 - 01/2015
3Pharmaceutical PreparationsIBA
05/2017 - 03/2011
1AmphetaminesIBA
01/2022
1Hallucinogens (Psychedelics)IBA
01/2022
1Clozapine (Clozaril)FDA LinkGeneric
01/2021
1Biological ProductsIBA
01/2021
1GABA AgentsIBA
01/2020
1Dopamine (Intropin)FDA LinkGeneric
01/2020
1gamma-Aminobutyric Acid (GABA)IBA
10/2019
1Polytetrafluoroethylene (Teflon)FDA Link
01/2019
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
03/2011
1Analgesics (Analgesic Drugs)IBA
03/2011

Therapy/Procedure

8Therapeutics
03/2022 - 03/2011
2Endurance Training
10/2021 - 03/2021
1Telescopes
12/2019
1Epidural Anesthesia
02/2013
1Prostheses and Implants (Prosthesis)
10/2012
1Splints (Splint)
03/2011
1Induced Hyperthermia (Thermotherapy)
03/2011